RAP 0.00% 20.5¢ raptor resources limited

Ann: Quarterly Update and Appendix 4C, page-3

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,962 Posts.
    lightbulb Created with Sketch. 1616
    Results from Australian paediatric study accepted for publication in peer-reviewed
    journal. A publication titled, “A prospective multicentre study testing the diagnostic accuracy
    of an automated cough sound centred analytic system for the identification of common
    respiratory disorders in children” has been accepted for publication by the peer-reviewed
    medical journal Respiratory Research. The publication summarises results from the
    Australian Breathe Easy pivotal study, a prospective, multi-centre study which compared the
    diagnosis of paediatric respiratory illness using ResApp’s cough-based algorithms to clinical
    diagnosis. The study analysed 585 subjects aged 29 days to 12 years of age. The positive
    percent and negative percent agreement values between the algorithms and the clinical
    reference were as follows: asthma (97%, 91%); pneumonia (87%, 85%); lower respiratory tract
    disease (83%, 82%); croup (88%, 86%); bronchiolitis (84%, 81%). Data from ResApp’s
    SMARTCOUGH-C-2 paediatric pivotal study will also be presented at the American Thoracic
    Society (ATS) 2019 International Conference, May 17-22nd in Dallas, Texas.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.